Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits
Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 594-594
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Clinical applications of stem cell-derived exosomes
Fei Tan, Xuran Li, Zhao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 201
Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies
Meng Xu, Tao Feng, Bowen Liu, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8926-8944
Open Access | Times Cited: 154
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Bioactive Materials (2023) Vol. 29, pp. 16-35
Open Access | Times Cited: 46
Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease
Tong Yin, Yan Liu, Wenbo Ji, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1264-1285
Open Access | Times Cited: 45
Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications
Chunhao Yang, Yunxin Xue, Yu Duan, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1089-1123
Closed Access | Times Cited: 40
Exosome-mediated delivery and regulation in neurological disease progression
Gurpreet Singh, Ankit Mehra, Sanchit Arora, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130728-130728
Open Access | Times Cited: 28
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Zeinab Nouri, Ashkan Barfar, Sahra Perseh, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway
Nesrine Ebrahim, Hajer A. Al Saihati, Zahraa Alali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116836-116836
Open Access | Times Cited: 15
A simple polydopamine‐based platform for engineering extracellular vesicles with brain‐targeting peptide and imaging probes to improve stroke outcome
Xiaojing Shi, Lu Zhang, Sheng‐Ju Wu, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
Hadi Yari, M. V. Mikhailova, Mahsa Mardasi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
Mohaddeseh Rahbaran, Angelina Olegovna Zekiy, Mahta Bahramali, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez‐López, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 298-298
Open Access | Times Cited: 23
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Jasmina Isaković, Klara Šerer, Barbara Barišić, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 23
Mesenchymal and Neural Stem Cell-Derived Exosomes in Treating Alzheimer’s Disease
Hongmin Wang, Christa C. Huber, Xiaoping Li
Bioengineering (2023) Vol. 10, Iss. 2, pp. 253-253
Open Access | Times Cited: 22
Promoting Alzheimer’s disease research and therapy with stem cell technology
Zimeng Cao, Fanshu Kong, Jiaqi Ding, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Mesenchymal stem cell-derived extracellular vesicles: A novel promising neuroprotective agent for Alzheimer's disease
Jun Chang, Zihang Feng, Yujiao Li, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116064-116064
Closed Access | Times Cited: 10
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Mingyue Sun, Zhuoyou Chen
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3921-3948
Open Access | Times Cited: 10
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Rajni Daksh, Meby Susan Mathew, Aan Mery Bosco, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 754, pp. 151526-151526
Open Access | Times Cited: 1
Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics
Hagar M. Soliman, Ghada A. Ghonaim, Shaza M. Gharib, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10794-10794
Open Access | Times Cited: 54
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
Charysse Vandendriessche, Dimitrios Kapogiannis, Roosmarijn E. Vandenbroucke
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114486-114486
Open Access | Times Cited: 30
The future of stem cell therapies of Alzheimer’s disease
Zhibo Wang, Zuo-Teng Wang, Yan Sun, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101655-101655
Closed Access | Times Cited: 29
Exploring potential of exosomes drug delivery system in the treatment of cancer: Advances and prospective
Deepika Yadav, Rishabha Malviya
Medicine in Drug Discovery (2023) Vol. 20, pp. 100163-100163
Open Access | Times Cited: 16
Enhanced Nose-to-Brain Delivery of Combined Small Interfering RNAs Using Lesion-Recognizing Nanoparticles for the Synergistic Therapy of Alzheimer’s Disease
Jiaxin Li, Huan Peng, Wei Zhang, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 46, pp. 53177-53188
Closed Access | Times Cited: 16
Extracellular vesicles in Alzheimer’s disease: from pathology to therapeutic approaches
AvneshS Thakor, Marta Garcia‐Contreras
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 18-18
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top